HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma
Loading...
Date
Authors
Stevens, W.B.C. Wendy
Bakunina, K.
Cuijpers, M.
Chamuleau, M.
Beeker, A.
Fijnheer, R.
Hebart, H.
Visser, H.P.J.
Doorduijn, J.K.
Linton, K.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Supplemental Digital Content is available in the text.